Corium International Inc.   Report issue

For profit Phase 1
Founded: Menlo Park CA United States (1995)
Status: No NME R&D (1995)

Organization Overview

First Clinical Trial
2016
NCT02968719
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Corium, Inc. | Corium International | Corium International Inc.

Active Ingredients

Drugs in Phase 1 Trials (1)

donepezil (aricept) (6 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 6
  • # of Trial APIs: 1